Researchers examined the association between micronutrient intake and the risk for ulcerative colitis.
PF-07265803 is an investigational selective, oral, small-molecule inhibitor of the p38a mitogen activated protein kinase pathway.
Many clinical trials supporting cancer drug approvals are ineligible for individual participant data sharing, a new study suggests.
Researchers examined changes in fecal metabolites resulting from either the Crohn disease exclusion diet plus enteral nutrition or the exclusive enteral nutrition diet and the association with remission.
Using a symptom tracker app, researchers assessed the risk for long COVID among patients infected with the Delta or the Omicron variant between 2 time periods.
The APOLLO-B study included patients 18 years of age and older with ATTR amyloidosis (hereditary or wild-type) with cardiomyopathy.
NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes.
The approval of Cimerli was based on a comprehensive analytical, preclinical and clinical program including the phase 3 COLUMBUS-AMD study.
Rebinyn is a recombinant DNA-derived coagulation Factor IX concentrate with an extended half-life.
The FDA has approved Kyzatrex (testosterone undecanoate) for the treatment of primary and secondary hypogonadism in adult males.
The sNDA is supported by data from the phase 3 CANDLE study.
Panel recommends counseling all women aged 40 to 60 years on healthy eating and physical activity to maintain weight or prevent weight gain.
The approval is supported by evidence from adequate and well-controlled studies of Stelara.
CTP-543 is an investigational oral selective inhibitor of JAK1 and JAK2.
The approval was based on data from the two phase 3 trials that included patients aged 12 years and older with mild to severe plaque psoriasis.
The CheckMate -914 trial included patients with localized RCC who underwent radical or partial nephrectomy and who were at high risk of relapse.
The 26-week ONWARDS 3 and 4 clinical trials evaluated the efficacy and safety of insulin icodec in adults with type 2 diabetes.
Modifying smoking behavior may lower the risk of developing severe glaucoma or losing vision.
Researchers sought to determine the prevalence and risk factors for colorectal neoplasia in adults younger than 50 years.
Approval was based on a prospective study that included 44 participants who underwent C-section delivery.